A phase I study of cisplatin, etoposide, and paclitaxel in small cell lung cancer

被引：0
|
作者：
Bunn, PA [1 ]
Kelly, K [1 ]
机构：
[1] UNIV COLORADO, CTR CANC, LUNG CANC PROGRAM, DENVER, CO 80262 USA
来源：
SEMINARS IN ONCOLOGY | 1997年 / 24卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：144 / 148
页数：5
相关论文
共 50 条
  • [21] Phase I study of etoposide, cisplatin and irinotecan triplet in patients with advanced-stage small-cell lung cancer
    E. Briasoulis
    E. Samantas
    H. Kalofonos
    D. Skarlos
    T. Makatsoris
    C. Christodoulou
    G. Fountzilas
    A. Bamias
    M.A. Dimopoulos
    P. Kosmidis
    N. Pavlidis
    Cancer Chemotherapy and Pharmacology, 2005, 56 : 521 - 528
  • [22] Phase II study of paclitaxel and cisplatin in patients with non-small cell lung cancer
    vonPawel, J
    Wagner, H
    Niederle, N
    Heider, A
    Koschel, G
    Hecker, D
    Hanske, M
    SEMINARS IN ONCOLOGY, 1996, 23 (06) : 47 - 50
  • [23] Phase I study of a carboplatin-cisplatin-etoposide combination chemotherapy in advanced non-small-cell lung cancer
    Nakano, H
    Tsuchiya, S
    Takei, Y
    Minato, K
    Watanabe, S
    Makimoto, T
    Naruse, I
    Nomoto, T
    Ishihara, S
    Takise, A
    Ezawa, K
    Fueki, N
    Hoshino, H
    Saito, R
    Mori, M
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1996, 19 (03): : 245 - 248
  • [24] Phase I study of etoposide, cisplatin and irinotecan triplet in patients with advanced-stage small-cell lung cancer
    Briasoulis, E
    Samantas, E
    Kalofonos, H
    Skarlos, D
    Makatsoris, T
    Christodoulou, C
    Fountzilas, G
    Bamias, A
    Dimopoulos, MA
    Kosmidis, P
    Pavlidis, N
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2005, 56 (05) : 521 - 528
  • [25] A Phase I/II study of docetaxel, etoposide, and carboplatin before concurrent chemoradiotherapy with cisplatin and etoposide in limited-stage small cell lung cancer
    Patrapim Sunpaweravong
    Lyn Magree
    Rachel Rabinovitch
    Paul Bunn
    Karen Kelly
    Investigational New Drugs, 2006, 24 : 213 - 221
  • [26] A Phase I/II study of docetaxel, etoposide, and carboplatin before concurrent chemoradiotherapy with cisplatin and etoposide in limited-stage small cell lung cancer
    Sunpaweravong, P
    Magree, L
    Rabinovitch, R
    Bunn, P
    Kelly, K
    INVESTIGATIONAL NEW DRUGS, 2006, 24 (03) : 213 - 221
  • [27] Phase I/II trial of gemcitabine plus cisplatin and etoposide in patients with small-cell lung cancer
    De Marinis, F
    Migliorino, MR
    Paoluzzi, L
    Portalone, L
    Ariganello, O
    Cortesi, E
    Gamucci, T
    Gasperoni, S
    Cipri, A
    Martelli, O
    Nelli, F
    LUNG CANCER, 2003, 39 (03) : 331 - 338
  • [28] Phase I/II study of cisplatin combined with weekly paclitaxel in patients with advanced non-small-cell lung cancer
    Yoshimura, N
    Kudoh, S
    Mukohara, T
    Yamauchi, S
    Yamada, M
    Kawaguchi, T
    Nakaoka, Y
    Hirata, K
    Yoshikawa, J
    BRITISH JOURNAL OF CANCER, 2004, 90 (06) : 1184 - 1189
  • [29] A phase I study of paclitaxel in combination with etoposide in patients with stage IIIB/IV non-small cell lung cancer (NSCLC)
    Ukena, D
    Berg, M
    Leutz, M
    Zell, L
    Schlimmer, P
    Sybrecht, GW
    LUNG CANCER, 1998, 19 (01) : 31 - 36
  • [30] Phase I/II study of cisplatin combined with weekly paclitaxel in patients with advanced non-small-cell lung cancer
    N Yoshimura
    S Kudoh
    T Mukohara
    S Yamauchi
    M Yamada
    T Kawaguchi
    Y Nakaoka
    K Hirata
    J Yoshikawa
    British Journal of Cancer, 2004, 90 : 1184 - 1189
12345